Web-based MINDfulness and Skills-based distress reduction in cancer (MINDS): study protocol for a multicentre observational healthcare study.
mental health
oncology
telemedicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
13 08 2020
13 08 2020
Historique:
entrez:
15
8
2020
pubmed:
15
8
2020
medline:
15
5
2021
Statut:
epublish
Résumé
Although a high percentage of patients with cancer experience severe psychological distress, few of them receive psycho-oncological care, largely due to barriers on the side of patients and healthcare providers that pose great challenges to delivering such care. In response, low-threshold, self-guided eHealth interventions can enable patients with cancer to deal independently and effectively with disease-related challenges and distress. Mindfulness and Skills-Based Distress Reduction in Oncology Training, nicknamed Make It Training, is one such innovative, self-guided eHealth intervention. In our study, we propose to assess different characteristics of such patients in order to define target populations for Make It Training, evaluate the intervention in terms of its usability, feasibility and sustainability and gather longitudinal data concerning the intervention's efficacy. Self-guided and web-based Make It Training consists of eight 30 min modules involving the use of techniques of mindfulness therapy, cognitive-behavioural therapy and acceptance and commitment therapy to be completed in a 4-month period. In our observational study, adult patients with cancer who possess adequate German language skills and provide their informed consent will be recruited at Essen, Erlangen and Tübingen University Hospitals at outpatient oncological institutions and via online channels. Patients will undergo a baseline online assessment (T0), an assessment directly after completing the intervention (T1) and assessments 3 and 6 months later (T2 and T3, respectively). With the results of those assessments, we will perform descriptive analyses of their sociodemographic and medical data, compare means and conduct regression analyses. The Ethics Committees of the University Hospitals Essen, Erlangen and Tübingen have approved the study (19-8643-BO, 27_19 B, 293/2018BO1). Results will be published in peer-reviewed journals and conference presentations. DRKS00017119.
Identifiants
pubmed: 32792437
pii: bmjopen-2019-036466
doi: 10.1136/bmjopen-2019-036466
pmc: PMC7430431
doi:
Banques de données
DRKS
['DRKS00017119']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e036466Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Annu Rev Clin Psychol. 2016;12:157-79
pubmed: 26652054
J Med Internet Res. 2016 Aug 31;18(8):e234
pubmed: 27582341
Ann Behav Med. 2007 Oct;34(2):115-34
pubmed: 17927551
J Evid Based Complementary Altern Med. 2017 Apr;22(2):348-360
pubmed: 27489233
World Psychiatry. 2019 Feb;18(1):20-28
pubmed: 30600624
Soc Work Health Care. 1999;29(2):39-67
pubmed: 10576251
Psychooncology. 2013 Jul;22(7):1457-65
pubmed: 22961994
Psychooncology. 2015 Dec;24(12):1784-91
pubmed: 26042392
Lancet Oncol. 2011 Feb;12(2):160-74
pubmed: 21251875
Patient Educ Couns. 2012 Mar;86(3):288-96
pubmed: 21798685
Psychooncology. 2014 Jan;23(1):9-19
pubmed: 23897834
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychooncology. 2017 Feb;26(2):222-230
pubmed: 26988800
World Psychiatry. 2014 Oct;13(3):288-95
pubmed: 25273302
Psychooncology. 2017 Apr;26(4):537-543
pubmed: 27327213
J Pain Symptom Manage. 2003 Apr;25(4):344-56
pubmed: 12691686
Qual Life Res. 2012 Nov;21(9):1551-64
pubmed: 22200938
J Clin Oncol. 2013 Feb 20;31(6):782-93
pubmed: 23319686
Psychother Psychosom Med Psychol. 2015 May;65(5):177-82
pubmed: 25485601
Psychooncology. 2012 Sep;21(9):1016-25
pubmed: 21608075
J Affect Disord. 2015 Nov 15;187:136-41
pubmed: 26331687
Cancer. 2013 Jan 1;119(1):201-14
pubmed: 22744865
Psychother Psychosom. 2016;85(5):289-96
pubmed: 27508418
J Med Internet Res. 2009 Apr 24;11(2):e13
pubmed: 19403466
J Clin Oncol. 2018 Mar 10;36(8):780-788
pubmed: 29369731
J Clin Oncol. 2014 Nov 1;32(31):3540-6
pubmed: 25287821
Psychooncology. 2014 Jun;23(6):601-12
pubmed: 24519814
Psychooncology. 2011 Feb;20(2):115-26
pubmed: 20336645
Psychother Psychosom Med Psychol. 2019 Oct;69(9-10):407-412
pubmed: 30731509
EJC Suppl. 2014 Jun;12(1):54-64
pubmed: 26217166
Psychooncology. 2018 Jan;27(1):75-82
pubmed: 28568377
Crit Rev Oncol Hematol. 2015 Jul;95(1):26-37
pubmed: 25701515
Cogn Behav Ther. 2011;40(4):251-66
pubmed: 22060248
JMIR Cancer. 2017 Nov 24;3(2):e19
pubmed: 29175813
Support Care Cancer. 2019 Jun;27(6):2221-2228
pubmed: 30315427
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
BMJ Open. 2018 Nov 8;8(11):e024794
pubmed: 30413519
Expert Rev Pharmacoecon Outcomes Res. 2007 Jun;7(3):291-7
pubmed: 20528315
Psychol Med. 2009 May;39(5):705-12
pubmed: 18812006
Patient Educ Couns. 2015 Mar;98(3):267-8
pubmed: 25628051
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
BMJ Open. 2019 Mar 1;9(3):e024862
pubmed: 30826763
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Ann Oncol. 2010 May;21(5):925-30
pubmed: 19887467